Concepts (237)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Flavonoids | 15 | 2022 | 443 | 1.960 |
Why?
|
| Anthocyanins | 7 | 2022 | 79 | 0.900 |
Why?
|
| Flavonols | 5 | 2020 | 83 | 0.900 |
Why?
|
| Isoflavones | 7 | 2008 | 139 | 0.770 |
Why?
|
| Diet | 22 | 2022 | 7939 | 0.730 |
Why?
|
| Estrogens, Non-Steroidal | 3 | 2003 | 54 | 0.660 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2014 | 194 | 0.430 |
Why?
|
| Trans Fatty Acids | 1 | 2014 | 153 | 0.430 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2014 | 546 | 0.370 |
Why?
|
| Plants | 1 | 2008 | 316 | 0.300 |
Why?
|
| Soy Foods | 2 | 2006 | 48 | 0.290 |
Why?
|
| Dietary Fats | 2 | 2016 | 2017 | 0.290 |
Why?
|
| Metabolome | 3 | 2019 | 895 | 0.280 |
Why?
|
| Flavanones | 4 | 2015 | 71 | 0.280 |
Why?
|
| Premenopause | 3 | 2006 | 1033 | 0.280 |
Why?
|
| Flavones | 3 | 2020 | 66 | 0.280 |
Why?
|
| Body Composition | 3 | 2014 | 2401 | 0.270 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2015 | 1790 | 0.260 |
Why?
|
| Fruit | 3 | 2019 | 1142 | 0.230 |
Why?
|
| Lignans | 3 | 2014 | 81 | 0.220 |
Why?
|
| Genistein | 1 | 2003 | 88 | 0.220 |
Why?
|
| Soybean Proteins | 1 | 2003 | 61 | 0.220 |
Why?
|
| Adiponectin | 1 | 2008 | 1100 | 0.220 |
Why?
|
| Tea | 2 | 2020 | 275 | 0.200 |
Why?
|
| Vitamin B 6 | 1 | 2022 | 237 | 0.190 |
Why?
|
| Fragaria | 1 | 2019 | 21 | 0.180 |
Why?
|
| Nutrition Assessment | 6 | 2020 | 723 | 0.180 |
Why?
|
| Biological Availability | 3 | 2006 | 397 | 0.170 |
Why?
|
| Muscle, Skeletal | 2 | 2014 | 4931 | 0.170 |
Why?
|
| Postmenopause | 3 | 2008 | 2461 | 0.160 |
Why?
|
| Eating | 3 | 2016 | 1536 | 0.160 |
Why?
|
| Inflammation | 2 | 2015 | 10638 | 0.150 |
Why?
|
| Phthalic Acids | 1 | 2022 | 436 | 0.150 |
Why?
|
| Diet Records | 3 | 2020 | 425 | 0.150 |
Why?
|
| Patient Compliance | 2 | 2018 | 2684 | 0.150 |
Why?
|
| Phenols | 2 | 2011 | 497 | 0.140 |
Why?
|
| Diet Surveys | 1 | 2020 | 1173 | 0.140 |
Why?
|
| Pyrus | 1 | 2015 | 12 | 0.130 |
Why?
|
| Diabetes Mellitus, Type 2 | 5 | 2021 | 11725 | 0.130 |
Why?
|
| Pulmonary Ventilation | 1 | 2018 | 373 | 0.130 |
Why?
|
| Food, Fortified | 2 | 2008 | 191 | 0.130 |
Why?
|
| Feeding Behavior | 6 | 2021 | 3188 | 0.130 |
Why?
|
| Potassium, Dietary | 1 | 2015 | 96 | 0.130 |
Why?
|
| Phytoestrogens | 3 | 2006 | 61 | 0.130 |
Why?
|
| Malus | 1 | 2015 | 48 | 0.130 |
Why?
|
| Diet, Mediterranean | 2 | 2018 | 700 | 0.130 |
Why?
|
| Estrogen Receptor beta | 2 | 2006 | 175 | 0.130 |
Why?
|
| 4-Butyrolactone | 1 | 2014 | 63 | 0.120 |
Why?
|
| Denmark | 3 | 2021 | 738 | 0.120 |
Why?
|
| Cholecalciferol | 1 | 2018 | 537 | 0.110 |
Why?
|
| Middle Aged | 26 | 2022 | 213383 | 0.110 |
Why?
|
| Milk | 1 | 2016 | 450 | 0.110 |
Why?
|
| Terminology as Topic | 1 | 2020 | 1547 | 0.110 |
Why?
|
| Motor Activity | 2 | 2015 | 2714 | 0.110 |
Why?
|
| Environmental Pollutants | 1 | 2022 | 1179 | 0.110 |
Why?
|
| Osteoporosis, Postmenopausal | 2 | 2008 | 386 | 0.110 |
Why?
|
| Plant Preparations | 2 | 2003 | 94 | 0.110 |
Why?
|
| Dietary Supplements | 3 | 2019 | 3297 | 0.110 |
Why?
|
| Prospective Studies | 14 | 2022 | 53288 | 0.110 |
Why?
|
| Absorptiometry, Photon | 3 | 2014 | 1725 | 0.100 |
Why?
|
| Female | 33 | 2022 | 380194 | 0.100 |
Why?
|
| Cross-Sectional Studies | 6 | 2021 | 25043 | 0.100 |
Why?
|
| Intestinal Absorption | 2 | 2003 | 420 | 0.100 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 651 | 0.100 |
Why?
|
| Body Mass Index | 5 | 2016 | 12720 | 0.100 |
Why?
|
| Glaucoma | 1 | 2021 | 1159 | 0.100 |
Why?
|
| Humans | 44 | 2024 | 744343 | 0.100 |
Why?
|
| Risk Factors | 15 | 2022 | 72290 | 0.090 |
Why?
|
| Adult | 21 | 2022 | 214055 | 0.090 |
Why?
|
| Energy Intake | 2 | 2015 | 2148 | 0.090 |
Why?
|
| Lipids | 1 | 2020 | 3305 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2024 | 21746 | 0.090 |
Why?
|
| Obesity | 4 | 2021 | 12745 | 0.080 |
Why?
|
| Myocardial Ischemia | 1 | 2019 | 2148 | 0.080 |
Why?
|
| Osteoporosis | 1 | 2018 | 1580 | 0.080 |
Why?
|
| Sarcopenia | 1 | 2014 | 368 | 0.080 |
Why?
|
| Incidence | 7 | 2022 | 20947 | 0.080 |
Why?
|
| Multivariate Analysis | 4 | 2015 | 12245 | 0.080 |
Why?
|
| Aged | 17 | 2022 | 163280 | 0.080 |
Why?
|
| Linear Models | 2 | 2016 | 5952 | 0.080 |
Why?
|
| Male | 23 | 2022 | 350118 | 0.080 |
Why?
|
| Prenatal Nutritional Physiological Phenomena | 1 | 2009 | 159 | 0.080 |
Why?
|
| Parkinson Disease | 1 | 2022 | 2775 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.080 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2022 | 3047 | 0.080 |
Why?
|
| Epidemiology | 1 | 2010 | 287 | 0.070 |
Why?
|
| Cardiovascular Diseases | 5 | 2019 | 15165 | 0.070 |
Why?
|
| Thiocyanates | 1 | 2006 | 70 | 0.070 |
Why?
|
| Glioma | 1 | 2021 | 3401 | 0.070 |
Why?
|
| Cognition | 1 | 2024 | 6770 | 0.070 |
Why?
|
| Proportional Hazards Models | 5 | 2021 | 12354 | 0.070 |
Why?
|
| Cohort Studies | 8 | 2021 | 40561 | 0.070 |
Why?
|
| Neoplasms | 4 | 2022 | 21683 | 0.070 |
Why?
|
| Nutrition Surveys | 2 | 2022 | 1660 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2019 | 3265 | 0.060 |
Why?
|
| Blood Pressure | 1 | 2020 | 8554 | 0.060 |
Why?
|
| Anticarcinogenic Agents | 1 | 2006 | 253 | 0.060 |
Why?
|
| Sulfates | 1 | 2005 | 390 | 0.060 |
Why?
|
| Follow-Up Studies | 7 | 2022 | 39050 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2019 | 3445 | 0.060 |
Why?
|
| Life Style | 2 | 2019 | 3835 | 0.060 |
Why?
|
| Bone and Bones | 2 | 2018 | 2575 | 0.060 |
Why?
|
| Antioxidants | 1 | 2011 | 1663 | 0.060 |
Why?
|
| Self Report | 3 | 2021 | 3558 | 0.060 |
Why?
|
| Chromans | 1 | 2003 | 122 | 0.050 |
Why?
|
| Infant Food | 1 | 2003 | 141 | 0.050 |
Why?
|
| Aged, 80 and over | 7 | 2022 | 57776 | 0.050 |
Why?
|
| Plasticizers | 1 | 2022 | 47 | 0.050 |
Why?
|
| Metabolic Clearance Rate | 1 | 2003 | 380 | 0.050 |
Why?
|
| Pyridoxal Phosphate | 1 | 2022 | 127 | 0.050 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 1 | 2003 | 361 | 0.050 |
Why?
|
| Carbon Isotopes | 1 | 2003 | 467 | 0.050 |
Why?
|
| Half-Life | 1 | 2003 | 661 | 0.050 |
Why?
|
| Environmental Exposure | 2 | 2022 | 4234 | 0.050 |
Why?
|
| Young Adult | 6 | 2022 | 56430 | 0.050 |
Why?
|
| Twins, Monozygotic | 2 | 2016 | 458 | 0.050 |
Why?
|
| Food Analysis | 1 | 2021 | 104 | 0.050 |
Why?
|
| Bone Density | 2 | 2018 | 3468 | 0.050 |
Why?
|
| Birth Weight | 1 | 2009 | 2069 | 0.050 |
Why?
|
| Isomerism | 1 | 2020 | 201 | 0.050 |
Why?
|
| Anthropometry | 2 | 2018 | 1350 | 0.050 |
Why?
|
| Vegetables | 2 | 2016 | 1182 | 0.050 |
Why?
|
| England | 2 | 2011 | 522 | 0.040 |
Why?
|
| Cholesterol, HDL | 1 | 2006 | 1814 | 0.040 |
Why?
|
| Tissue Distribution | 1 | 2003 | 2327 | 0.040 |
Why?
|
| Europe | 2 | 2018 | 3339 | 0.040 |
Why?
|
| Sex Factors | 2 | 2017 | 10397 | 0.040 |
Why?
|
| Endothelial Cells | 1 | 2011 | 3479 | 0.040 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 1889 | 0.040 |
Why?
|
| Parathyroid Hormone | 2 | 2018 | 1801 | 0.040 |
Why?
|
| Aging | 1 | 2016 | 8664 | 0.040 |
Why?
|
| Adolescent | 4 | 2018 | 85781 | 0.040 |
Why?
|
| Valerates | 1 | 2016 | 21 | 0.040 |
Why?
|
| Femur Neck | 1 | 2018 | 309 | 0.040 |
Why?
|
| Depression | 1 | 2016 | 7766 | 0.040 |
Why?
|
| Phenol | 1 | 2016 | 43 | 0.040 |
Why?
|
| Uridine | 1 | 2016 | 146 | 0.030 |
Why?
|
| Caffeic Acids | 1 | 2015 | 13 | 0.030 |
Why?
|
| Coumaric Acids | 1 | 2015 | 14 | 0.030 |
Why?
|
| Hesperidin | 1 | 2015 | 16 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2003 | 2203 | 0.030 |
Why?
|
| Food | 1 | 2020 | 771 | 0.030 |
Why?
|
| Catechin | 1 | 2015 | 66 | 0.030 |
Why?
|
| Vital Capacity | 1 | 2018 | 925 | 0.030 |
Why?
|
| Menopause | 1 | 2003 | 1626 | 0.030 |
Why?
|
| Spirometry | 1 | 2018 | 864 | 0.030 |
Why?
|
| Quercetin | 1 | 2015 | 93 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2020 | 2886 | 0.030 |
Why?
|
| Blood Chemical Analysis | 1 | 2016 | 440 | 0.030 |
Why?
|
| United States | 3 | 2019 | 69872 | 0.030 |
Why?
|
| Urinary Bladder Neoplasms | 1 | 2006 | 2245 | 0.030 |
Why?
|
| Oxidative Stress | 2 | 2018 | 3086 | 0.030 |
Why?
|
| Quality Control | 1 | 2016 | 841 | 0.030 |
Why?
|
| Endometrial Neoplasms | 1 | 2003 | 1353 | 0.030 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 19905 | 0.030 |
Why?
|
| Micronutrients | 1 | 2016 | 375 | 0.030 |
Why?
|
| Seafood | 1 | 2016 | 384 | 0.030 |
Why?
|
| Registries | 1 | 2008 | 8089 | 0.030 |
Why?
|
| Prevalence | 2 | 2021 | 15226 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2020 | 4933 | 0.030 |
Why?
|
| Amino Acids | 1 | 2018 | 1736 | 0.030 |
Why?
|
| Coffee | 1 | 2016 | 578 | 0.030 |
Why?
|
| Blood Glucose | 1 | 2006 | 6256 | 0.020 |
Why?
|
| Multilevel Analysis | 1 | 2011 | 142 | 0.020 |
Why?
|
| Dietary Carbohydrates | 1 | 2016 | 906 | 0.020 |
Why?
|
| Dietary Proteins | 1 | 2016 | 963 | 0.020 |
Why?
|
| Cause of Death | 1 | 2021 | 3584 | 0.020 |
Why?
|
| Population Surveillance | 1 | 2021 | 2616 | 0.020 |
Why?
|
| Vitamin D | 2 | 2018 | 3223 | 0.020 |
Why?
|
| Collagen | 1 | 2018 | 2689 | 0.020 |
Why?
|
| Mortality | 1 | 2021 | 2864 | 0.020 |
Why?
|
| Stilbenes | 1 | 2010 | 156 | 0.020 |
Why?
|
| Interleukin-18 | 1 | 2011 | 249 | 0.020 |
Why?
|
| Twins, Dizygotic | 1 | 2009 | 236 | 0.020 |
Why?
|
| Age Factors | 1 | 2006 | 18370 | 0.020 |
Why?
|
| Peripheral Arterial Disease | 1 | 2019 | 1188 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2011 | 357 | 0.020 |
Why?
|
| Review Literature as Topic | 1 | 2010 | 336 | 0.020 |
Why?
|
| Coronary Disease | 1 | 2003 | 6077 | 0.020 |
Why?
|
| Procollagen | 1 | 2008 | 185 | 0.020 |
Why?
|
| Consumer Product Safety | 1 | 2008 | 122 | 0.020 |
Why?
|
| History, 19th Century | 1 | 2010 | 720 | 0.020 |
Why?
|
| Sulfoxides | 1 | 2006 | 48 | 0.020 |
Why?
|
| Isothiocyanates | 1 | 2006 | 51 | 0.020 |
Why?
|
| Comorbidity | 1 | 2021 | 10388 | 0.020 |
Why?
|
| Polymorphism, Genetic | 1 | 2017 | 4328 | 0.020 |
Why?
|
| Nurses | 1 | 2016 | 2461 | 0.020 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 6038 | 0.020 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2006 | 459 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2006 | 323 | 0.020 |
Why?
|
| Antidepressive Agents | 1 | 2016 | 2838 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2005 | 440 | 0.010 |
Why?
|
| Luciferases | 1 | 2005 | 733 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 758 | 0.010 |
Why?
|
| Double-Blind Method | 2 | 2008 | 12026 | 0.010 |
Why?
|
| Massachusetts | 1 | 2015 | 8663 | 0.010 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 697 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 928 | 0.010 |
Why?
|
| Lipoprotein(a) | 1 | 2006 | 435 | 0.010 |
Why?
|
| History, 20th Century | 1 | 2010 | 2740 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2011 | 6459 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2016 | 14722 | 0.010 |
Why?
|
| Infant | 1 | 2003 | 35136 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 9959 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2006 | 2029 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9583 | 0.010 |
Why?
|
| Apoptosis | 2 | 2006 | 9727 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2021 | 23338 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2005 | 3128 | 0.010 |
Why?
|
| Lung | 1 | 2018 | 9856 | 0.010 |
Why?
|
| C-Reactive Protein | 1 | 2011 | 3778 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2006 | 2967 | 0.010 |
Why?
|
| Estradiol | 1 | 2005 | 2020 | 0.010 |
Why?
|
| Cell Division | 1 | 2005 | 4568 | 0.010 |
Why?
|
| Animals | 2 | 2016 | 168757 | 0.010 |
Why?
|
| Cell Nucleus | 1 | 2006 | 2969 | 0.010 |
Why?
|
| Transfection | 1 | 2005 | 5892 | 0.010 |
Why?
|
| Adipose Tissue | 1 | 2009 | 3279 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2006 | 4217 | 0.010 |
Why?
|
| Stroke | 1 | 2019 | 9981 | 0.010 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2009 | 2408 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2011 | 7729 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 20822 | 0.010 |
Why?
|
| Peptide Fragments | 1 | 2008 | 5097 | 0.010 |
Why?
|
| Calcium | 1 | 2008 | 5756 | 0.010 |
Why?
|
| Base Sequence | 1 | 2006 | 12797 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2005 | 8436 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2005 | 5867 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2006 | 18111 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 7799 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2005 | 7722 | 0.010 |
Why?
|
| Genotype | 1 | 2006 | 12951 | 0.010 |
Why?
|
| Insulin | 1 | 2006 | 6580 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2006 | 10481 | 0.010 |
Why?
|
| Pregnancy | 1 | 2009 | 29144 | 0.000 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2006 | 15519 | 0.000 |
Why?
|
| Child | 1 | 2011 | 77709 | 0.000 |
Why?
|
Concepts
(237)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(20)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_